Cargando…
An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes
Caring for patients with type 2 diabetes mellitus (T2DM) has entered an era with many recent additions to the regimens used to clinically control their hyperglycemia. The most recent class of agents approved by the Food and Drug Administration (FDA) for T2DM is the sodium–glucose-linked transporter...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322811/ https://www.ncbi.nlm.nih.gov/pubmed/28255241 http://dx.doi.org/10.2147/VHRM.S105721 |